Skip to main content
. Author manuscript; available in PMC: 2011 Jun 20.
Published in final edited form as: Eur J Neurosci. 2010 Mar 8;31(6):1027–1042. doi: 10.1111/j.1460-9568.2010.07148.x

Figure 7.

Figure 7

Effect of DA antagonists was influenced by removal of GABAergic inhibition. In the presence of 50 μM PTX, the D1-like antagonist, SCH23390, completely blocked enhanced CRF-induced LTP in the cocaine-withdrawn group (B) but not CRF-induced LTP recorded in saline-treated group (A) in the presence of 50 μM PTX. The D2-like antagonist, raclopride, did not block CRF-induced LTP in saline-treated group (C) or in the cocaine-withdrawn group (D) when recorded in 50 μM PTX as compared to 10 μM PTX (Fig. 4).